Design Highlights
- Injured workers represent a significant portion of pharmacy utilization, yet their needs are often neglected in management strategies.
- Despite a decrease in opioid prescriptions, injured workers still rely heavily on other medications, highlighting their essential role in pharmacy trends.
- The complexities of navigating the pharmaceutical care system often leave injured workers overwhelmed, resulting in underutilization of available resources.
- Formulary changes, while intended to improve outcomes, can limit injured workers’ access to necessary medications, further marginalizing their voices in utilization discussions.
- Increased awareness and engagement opportunities could empower injured workers, transforming them from overlooked participants to influential stakeholders in pharmacy utilization.
Injured workers are maneuvering a tricky landscape when it comes to pharmacy utilization. It’s a convoluted mess, really. Opioid spending dipped by 15.1% in 2020 for payers managed by myMatrixx. That beats the overall drop in prescription utilization of 11.4%. However, the average spending per injured patient held steady, a mind-boggling $219.04 to $219.48. So, while everyone is tightening their belts, injured workers are stuck in a weird limbo.
Injured workers find themselves in a puzzling limbo as opioid spending dips but costs remain stubbornly high.
Here’s the kicker: more than half—51.7%—of payers spent less on opioids in 2020. Yet, 20% of injured workers were popping those pills for just 30 days or less. So what gives? It’s a game of numbers, and injured workers are caught in the crossfire. Meanwhile, opioid use per workers’ compensation claim fell by 9.7% in 2023, with costs per claim down 7.2%. Everyone’s cutting back, but not everyone is feeling the pinch.
Then there’s the whole formulary situation. Texas implemented a closed formulary that reduced total prescriptions by 11%. N-drug prescriptions? A whopping 77% drop. Sounds good, right? But it also means fewer options for injured workers, who may now find themselves in a precarious position.
Return-to-work rates shot up post-formulary, and suddenly, everyone is cheering. But at what cost? Mental and physical functioning scores improved, which is great. But let’s not forget, injured workers are still trying to maneuver a confusing system. Workers’ compensation drug spending increased by 2.2% last year, highlighting the financial pressures on these individuals.
Out-of-network channels add another layer of chaos. Many injured workers don’t even realize the ramifications of straying outside the network. They’re chasing convenience like it’s the Holy Grail, blissfully unaware of the pitfalls. Awareness of OON prescription drug channels is often low among injured workers, which complicates their choices. Direct engagement with these workers could boost network utilization, but who has the time?
And don’t even get started on the shifts in drug utilization. Specialty spend skyrocketed from 5.9% to 15.3% of total prescription spend. Migraine medications surged in 2023, leaving opioids and muscle relaxants in the dust. Just like how 1 in 3 pets requires emergency treatment annually, a significant portion of injured workers face unexpected medical complications that strain their already tight budgets.
The landscape is shifting, but injured workers? They’re still the underdogs, overlooked and underappreciated. It’s a wild ride for these injured workers maneuvering the pharmacy terrain. They are the ones who bear the brunt of these changes, struggling to find relief while the system twists and turns around them.
In this convoluted world of pharmacy utilization, they are, indeed, the overlooked powerhouse.
